Hair Loss Treatment Market, By Product Type (Corticosteroids, Antihypertensive, Topical Immune-modulators, Others), By Type (Noncicatricial (Telogen Effluvium, Androgenetic Alopecia, Alopecia Areata), Cicatricial, Others), By Route of Administration (Oral

Hair Loss Treatment Market, By Product Type (Corticosteroids, Antihypertensive, Topical Immune-modulators, Others), By Type (Noncicatricial (Telogen Effluvium, Androgenetic Alopecia, Alopecia Areata), Cicatricial, Others), By Route of Administration (Oral, Topical), By Gender (Male, Female ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Hair Loss Treatment Market, By Product Type (Corticosteroids, Antihypertensive, Topical Immune-modulators, Others), By Type (Noncicatricial (Telogen Effluvium, Androgenetic Alopecia, Alopecia Areata), Cicatricial, Others), By Route of Administration (Oral, Topical), By Gender (Male, Female ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Hair goes through a cycle of growing, resting, falling out, and regenerating. A hair loss is defined by the disruption of this cycle, or the damage to hair follicle, resulting in quick loss of hair. Receding hairline, hair falling out in patches, or overall thinning are some of the visible symptoms of hair loss. There are several types of hair loss such as telogen effluvium, androgenetic effluvium, and alopecia, areata, tinea capitis, cicatricial alopecia, hair shaft abnormalities, hypotrichosis. Several methods are used for diagnosis of hair loss such as blood test, pull test, scalp biopsy, light microscopy, and others. The treatment of hair loss includes medication such as finasteride, minoxidil, and other drugs. Moreover, surgical procedures such as hair transplant, laser therapy, and others are also used for treatment of hair loss.

Market Dynamics

The key market players are focusing on adoption of organic growth strategies such as product launches and approval, and this is expected to drive the global hair loss treatment market growth over the forecast period. Moreover, increasing incidence of alopecia or hair loss is also expected to drive the global hair loss treatment market growth over the forecast period. Increasing research and development activitives by key market players androbust pipeline of drug candidates used in treatment of hair loss is expected to propel the market growth. Growing level of stress due to the ever-changing human lifestyle is one of the major factors contributing to hair loss that boostsdemand for hair loss treatment products across the globe. For instance, in February 2022, according to an article published by Springer Nature, an open-access medical and scientific journal, , the stress level increases with increase in the age, and around 20% - 25% people of age 18 and above have moderate amount of stress

Key features of the study:

• The report provides an in-depth analysis of the global hair loss treatment market and provides market size (US$ Bn) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for the market.
• The study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global hair loss treatment market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Viviscal, Cipla Inc., Aclaris Therapeutics, Inc., Merck & Co., Inc., Daiichi-Sankyo Co., Ltd., Johnson and Johnson Services, Inc., Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH, PureTech, Vitabiotics, Reddy’s Laboratories, Ranbaxy Laboratories Ltd., HCell Inc., Follica, Inc., Aurobindo Pharma, and Zydus Lifesciences Inc.
• Insights from the report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global hair loss treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hair loss treatment market

Global Hair Loss Treatment Market Detailed Segmentation:

• By Product Type:
• Corticosteroids
• Antihypertensive
• Topical Immune-modulators
• Others
• By Type:
• Noncicatricial

Telogen Effluvium

Androgenetic Alopecia

Alopecia Areata

• Cicatricial
• Others
• By Route of Administration:
• Oral
• Topical
• By Gender:
• Male
• Female
• By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
• Company Profiles
• Viviscal
• Cipla Inc.
• Aclaris Therapeutics, Inc.
• Merck & Co., Inc.
• Daiichi-Sankyo Co., Ltd.
• Johnson and Johnson Services, Inc.
• Lexington International LLC
• Vita-Cos-Med Klett-Loch GmbH
• PureTech
• Vitabiotics
• Reddy’s Laboratories
• Ranbaxy Laboratories Ltd.
• HCell Inc.
• Follica, Inc.
• Aurobindo Pharma
• Zydus Lifesciences Inc.